Clinical Value of Dual-phase F-18 Sodium Fluoride PET/CT for Diagnosing Bone Metastasis in Cancer Patients with Solitary Bone Lesion
Overview
Authors
Affiliations
Background: The present study aimed to investigate whether dual-phase F-18 sodium-fluoride (NaF) positron emission tomography/computed tomography (PET/CT) could improve the diagnostic accuracy of detecting bone metastasis in cancer patients with a solitary bone lesion compared to conventional F-18 NaF PET/CT.
Methods: We retrospectively enrolled 113 cancer patients who underwent dual-phase F-18 NaF PET/CT for the differential diagnosis of a solitary bone lesion seen on bone scintigraphy. According to the dual-phase PET/CT protocol, an early-phase scan was acquired immediately after radiotracer injection and a conventional F-18 NaF PET/CT scan was performed. The diagnostic abilities of the visual analysis of conventional and dual-phase PET/CT scans and two quantitative parameters (lesion-to-blood pool uptake ratio on early-phase scan and lesion-to-bone uptake ratio on conventional scan) for detecting bone metastasis were compared. The final diagnosis of bone metastasis was made by histopathological confirmation or follow-up imaging studies.
Results: A metastatic bone lesion was diagnosed in 28 patients (24.8%). The sensitivity, specificity, and accuracy were 100.0%, 70.6%, and 77.9%, respectively, for visual analysis of conventional F-18 NaF PET/CT, 92.9%, 42.4%, 54.9%, respectively, for lesion-to-bone uptake ratio, 96.4%, 88.2%, and 90.3%, respectively, for visual analysis of dual-phase PET/CT, and 92.9%, 81.2%, and 83.2%, respectively, for lesion-to-blood pool uptake ratio. Visual analysis of dual-phase PET/CT was shown to have the highest area under the receiver operating characteristic curve value (0.923; 95% CI, 0.858-0.965) among all parameters.
Conclusions: Dual-phase F-18 NaF PET/CT showed a high diagnostic ability for detecting bone metastasis with improved specificity and accuracy compared to conventional F-18 NaF PET/CT in cancer patients. Dual-phase F-18 NaF PET/CT might help diagnose bone metastasis in patients with malignancies who were shown to have a solitary bone lesion on bone scintigraphy.
Yoo I, Hong S, Lee S, Yang H, Kim K, Kim S Diagnostics (Basel). 2024; 14(23).
PMID: 39682622 PMC: 11639772. DOI: 10.3390/diagnostics14232714.
Nappi C, Zampella E, Gaudieri V, Volpe F, Piscopo L, Vallone C J Clin Med. 2024; 13(2).
PMID: 38276075 PMC: 10816004. DOI: 10.3390/jcm13020569.
Wu J, Wang Y, Liao T, Rao Z, Gong W, Ou L Front Oncol. 2021; 11:737827.
PMID: 34604078 PMC: 8484883. DOI: 10.3389/fonc.2021.737827.
Park H, Chang S, Lee J, Lee S Quant Imaging Med Surg. 2021; 11(4):1156-1169.
PMID: 33816157 PMC: 7930669. DOI: 10.21037/qims-20-788.